Literature DB >> 25374292

Authors' reply to Gandjour: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".

A T Newall1, M Jit, R Hutubessy.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25374292     DOI: 10.1007/s40273-014-0232-0

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  4 in total

1.  Priority setting of public spending in developing countries: do not try to do everything for everybody.

Authors:  Rob Baltussen
Journal:  Health Policy       Date:  2005-11-21       Impact factor: 2.980

2.  Germany's decision rule for setting ceiling prices of drugs: a comparative analysis with other decision rules.

Authors:  Afschin Gandjour
Journal:  Appl Health Econ Health Policy       Date:  2011-03-01       Impact factor: 2.561

3.  Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines.

Authors:  A T Newall; M Jit; R Hutubessy
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

4.  Comment on: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".

Authors:  Afschin Gandjour
Journal:  Pharmacoeconomics       Date:  2014-12       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.